Arora Paul, Ramagopalan Sreeram V
Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, M5T 3M7, Canada.
Inka Health, Schwartz Reisman Innovation Campus, University of Toronto, Toronto, Ontario, M5G 0C6, Canada.
J Comp Eff Res. 2025 Jan;14(1):e240212. doi: 10.57264/cer-2024-0212. Epub 2024 Nov 27.
In this update, we discuss a position statement from the National Institute of Health and Care Excellence (NICE) on the use of artificial intelligence for evidence generation and publications reviewing the use of real-world data as external control arms. Finally, we discuss a number of recent studies investigating the real-world effectiveness of glucagon-like peptide-1 receptor agonists and whether these studies are informative for reimbursement decision making.
在本次更新中，我们讨论了英国国家卫生与临床优化研究所（NICE）关于使用人工智能进行证据生成以及审查将真实世界数据用作外部对照臂进行出版物发表的立场声明。最后，我们讨论了一些近期研究，这些研究调查了胰高血糖素样肽-1受体激动剂的真实世界有效性，以及这些研究对于报销决策是否具有参考价值。
